FDA stalled on CBD for now: Analyst
June 15, 2022 at 10:33 AM EDT
FDA expresses interest in more studies of CBD but no real action is expected without a push from Congress, according to Cowen analyst.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|